세계의 요도협착 치료 기기 시장 보고서(2025년)
Urethral Stricture Treatment Devices Global Market Report 2025
상품코드 : 1717338
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 175 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ₩ 6,448,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,490 ₩ 9,320,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 8,490 ₩ 12,193,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

요도협착 치료기 시장 규모는 향후 수년간 강력한 성장세를 보일 것으로 예상되며, 2029년까지 연평균 8.0% 성장하여 20억 1,000만 달러 규모에 달할 것으로 예측됩니다. 예측 기간 중의 성장은 외래 진료에 대한 수요 증가, 환자 중심 치료에 대한 관심 증가, 신흥 시장의 의료 인프라 확대, 외상 관련 규제 강화, 의료 기관이 주도하는 인식 개선 캠페인 등의 요인에 기인하는 것으로 보입니다. 예측 기간 중 주요 동향으로는 최소침습 수술로의 전환, 진단 툴에 인공지능(AI)의 통합, 수술 장비의 기술 발전, 의료 영상 기술의 향상, 개인 맞춤형 치료 솔루션에 대한 관심 등이 있습니다.

전립선비대증(BPH)과 신경인성 방광의 유병률 증가는 요도협착 치료 기기 시장의 성장을 가속할 것으로 예측됩니다. 전립선비대증은 전립선 비대로 인해 소변의 흐름을 방해하고 요도협착의 위험을 증가시키는 것이 특징이며, BPH 사례 증가는 주로 노화로 인해 50세 이상 남성에서 더 높은 빈도로 관찰되며, 생활습관, 호르몬 변화, 만성질환 등의 요인으로 인해 증가합니다. 요도협착 치료기는 BPH와 같은 비뇨기과적 문제를 관리할 때 자주 사용되지만, 수술 후의 영향이나 장기간의 카테터 삽입과 같은 합병증이 요도협착을 유발할 수 있습니다. 따라서 적절한 배뇨 기능을 회복하기 위해 확장기나 스텐트, 요도 절개기구의 사용이 필요할 수 있습니다. 예를 들어 2023년 9월 영국 왕립약사회에서 발표한 보고서에 따르면 영국에서는 약 300만 명이 BPH를 앓고 있으며, 60-70세 남성의 50%, 80세 이상 남성의 90%가 이 증상을 경험하고 있다고 합니다. 따라서 BPH와 신경인성 방광의 유병률 증가는 요도협착 치료 기기 시장의 성장에 기여할 것으로 예측됩니다.

요도협착 치료 기기 시장의 주요 업체들은 기술 통합을 개선하고 시장에서의 입지를 확대하기 위해 전략적 파트너십을 추구하고 있습니다. 전략적 파트너십은 두개 이상의 조직이 협력하여 서로의 목적을 달성하기 위해 자원과 전문 지식을 공유하는 것입니다. 예를 들어 2024년 4월, 미국에 본사를 둔 진단 및 치료 의료 기술 전문 기업인 Laborie Medical Technologies Corp.는 NHS Specialized Services Device Programme(SSDP)과 파트너십을 맺었습니다. 이번 파트너십을 통해 Laborie의 Optilume Urethral Drug-Coated Balloon(DCB)이 SSDP에 임베디드되어 영국 NHS 병원에 대한 상환을 보장하고 환자들의 접근성을 향상시킬 수 있게 되었습니다. 옵티륨은 풍선 확장술과 항증식제 전달을 결합하여 요도 협착의 재발을 억제하는 솔루션을 제공합니다. 이 혁신적인 최소침습적 기술은 기존의 수술이나 반복적인 치료의 대안으로 비뇨기과 분야의 중요한 니즈를 충족시킬 수 있습니다.

목차

제1장 개요

제2장 시장의 특징

제3장 시장 동향과 전략

제4장 시장 - 거시경제 시나리오 금리, 인플레이션, 지정학, 신형 코로나바이러스의 영향과 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

제6장 시장 세분화

제7장 지역별·국가별 분석

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 개요

제31장 기타 대기업과 혁신적 기업

제32장 세계의 시장 경쟁 벤치마킹과 대시보드

제33장 주요 합병과 인수

제34장 최근 시장 동향

제35장 시장의 잠재력이 높은 국가, 부문, 전략

제36장 부록

KSA
영문 목차

영문목차

Urethral stricture treatment devices are medical tools designed to address urethral stricture, a condition where the urethra becomes narrowed, often causing urinary retention and difficulty with urination. These devices work to widen or bypass the constricted area of the urethra, restoring normal urine flow, and are used in both surgical and non-surgical treatment options.

The primary products in urethral stricture treatment devices include urethral dilators, urethral stents, urethral balloon dilation catheters, and urinary catheters. Urethral dilators are instruments used to gradually widen or stretch a narrowed urethra, facilitating easier urine flow. They are commonly used in procedures to treat urethral strictures by progressively increasing the diameter of the urethra. The strictures may be located in either the anterior or posterior sections, and the devices are typically used by end users such as hospitals, specialty clinics, and other healthcare facilities.

The urethral stricture treatment devices market research report is one of a series of new reports from The Business Research Company that provides urethral stricture treatment devices market statistics, including urethral stricture treatment devices industry global market size, regional shares, competitors with a urethral stricture treatment devices market share, detailed urethral stricture treatment devices market segments, market trends and opportunities, and any further data you may need to thrive in the urethral stricture treatment devices industry. This urethral stricture treatment devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The urethral stricture treatment devices market size has grown strongly in recent years. It will grow from $1.37 billion in 2024 to $1.48 billion in 2025 at a compound annual growth rate (CAGR) of 8.3%. The growth during the historic period can be attributed to factors such as the increasing prevalence of urethral strictures, a greater adoption of minimally invasive treatments, heightened awareness of urological disorders, rising healthcare expenditure in developed regions, and advancements in diagnostic capabilities.

The urethral stricture treatment devices market size is expected to see strong growth in the next few years. It will grow to $2.01 billion in 2029 at a compound annual growth rate (CAGR) of 8.0%. The growth during the forecast period can be attributed to factors such as the rising demand for outpatient procedures, a growing focus on patient-centered care, the expansion of healthcare infrastructure in emerging markets, an increase in trauma-related strictures, and awareness campaigns led by healthcare organizations. Key trends in the forecast period include a shift toward minimally invasive surgeries, the integration of artificial intelligence (AI) in diagnostic tools, technological advancements in surgical devices, improvements in medical imaging techniques, and a focus on personalized treatment solutions.

The growing incidence of benign prostatic hyperplasia (BPH) and neurogenic bladder is expected to drive the growth of the urethral stricture treatment devices market. BPH is a common condition among older men, characterized by an enlarged prostate that can obstruct urinary flow and heighten the risk of urethral strictures. The rise in BPH cases is largely due to aging, with a higher frequency observed in men over 50, as well as factors such as lifestyle, hormonal changes, and chronic conditions. Urethral stricture treatment devices are often used in managing urological issues such as BPH, where complications such as post-surgical effects or prolonged catheterization may cause urethral narrowing. This may require the use of dilators, stents, or urethrotomy tools to restore proper urinary function. For example, a report from the Royal Pharmaceutical Society in September 2023 stated that approximately 3 million individuals in the UK are affected by BPH, with 50% of men aged 60-70 years and 90% of men over 80 years experiencing the condition. Therefore, the increasing prevalence of BPH and neurogenic bladder is expected to contribute to the growth of the urethral stricture treatment devices market.

Leading companies in the urethral stricture treatment devices market are pursuing strategic partnerships to improve technology integration and broaden their market presence. A strategic partnership involves two or more organizations working together, sharing resources and expertise to achieve mutual objectives. For example, in April 2024, Laborie Medical Technologies Corp., a US-based company specializing in diagnostic and therapeutic medical technologies, formed a partnership with the NHS Specialized Services Device Programme (SSDP). This collaboration enabled the inclusion of Laborie's Optilume Urethral Drug-Coated Balloon (DCB) in the program, ensuring reimbursement for NHS hospitals in England and improving patient access to the device. Optilume combines balloon dilation with anti-proliferative drug delivery, offering a solution to reduce the recurrence of urethral strictures. This innovative, minimally invasive technology provides an alternative to traditional surgery or repeated treatments, addressing a significant need within the field of urology.

In October 2023, Laborie Medical Technologies Corp., a US-based company specializing in diagnostic and therapeutic medical technologies, acquired Urotronic Inc. for an undisclosed sum. This acquisition allows Laborie to incorporate Urotronic's Optilume drug-coated balloon technology into its range of interventional urology solutions. The technology is designed to treat conditions such as urethral strictures and benign prostatic hyperplasia (BPH). Urotronic Inc. is a US-based medical device company focused on developing urethral stricture treatment devices and other urological treatment technologies.

Major players in the urethral stricture treatment devices market are Cardinal Health, Medtronic plc, Siemens Healthineers AG, Medline Industries LP., Becton Dickinson and Company, Stryker Corporation, Boston Scientific Corporation, B. Braun SE, Olympus Corporation, Coloplast Ltd, Teleflex Incorporated, Karl Storz SE & Co. KG, Cook Medical, ConvaTec Inc., Ambu A/S, Richard Wolf GmbH, Laborie Medical Technologies, Bactiguard AB, UROMED Kurt Drews KG, Pnn Medical A/S, Hydrumedical SA, Allium Ltd., Med pro Medical B.V., Urotronic Inc., Rocamed SAM, and Zhejiang ChuangXiang Medical Technology Co. Ltd.

North America was the largest region in the urethral stricture treatment devices market in 2024. The regions covered in urethral stricture treatment devices report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the urethral stricture treatment devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The urethral stricture treatment devices market consists of sales of laser urethrotomy devices, biodegradable stents, lubricants, urethral calibration sets, and bougies. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Urethral Stricture Treatment Devices Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on urethral stricture treatment devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for urethral stricture treatment devices ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The urethral stricture treatment devices market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Scope

Table of Contents

1. Executive Summary

2. Urethral Stricture Treatment Devices Market Characteristics

3. Urethral Stricture Treatment Devices Market Trends And Strategies

4. Urethral Stricture Treatment Devices Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Urethral Stricture Treatment Devices Growth Analysis And Strategic Analysis Framework

6. Urethral Stricture Treatment Devices Market Segmentation

7. Urethral Stricture Treatment Devices Market Regional And Country Analysis

8. Asia-Pacific Urethral Stricture Treatment Devices Market

9. China Urethral Stricture Treatment Devices Market

10. India Urethral Stricture Treatment Devices Market

11. Japan Urethral Stricture Treatment Devices Market

12. Australia Urethral Stricture Treatment Devices Market

13. Indonesia Urethral Stricture Treatment Devices Market

14. South Korea Urethral Stricture Treatment Devices Market

15. Western Europe Urethral Stricture Treatment Devices Market

16. UK Urethral Stricture Treatment Devices Market

17. Germany Urethral Stricture Treatment Devices Market

18. France Urethral Stricture Treatment Devices Market

19. Italy Urethral Stricture Treatment Devices Market

20. Spain Urethral Stricture Treatment Devices Market

21. Eastern Europe Urethral Stricture Treatment Devices Market

22. Russia Urethral Stricture Treatment Devices Market

23. North America Urethral Stricture Treatment Devices Market

24. USA Urethral Stricture Treatment Devices Market

25. Canada Urethral Stricture Treatment Devices Market

26. South America Urethral Stricture Treatment Devices Market

27. Brazil Urethral Stricture Treatment Devices Market

28. Middle East Urethral Stricture Treatment Devices Market

29. Africa Urethral Stricture Treatment Devices Market

30. Urethral Stricture Treatment Devices Market Competitive Landscape And Company Profiles

31. Urethral Stricture Treatment Devices Market Other Major And Innovative Companies

32. Global Urethral Stricture Treatment Devices Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Urethral Stricture Treatment Devices Market

34. Recent Developments In The Urethral Stricture Treatment Devices Market

35. Urethral Stricture Treatment Devices Market High Potential Countries, Segments and Strategies

36. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기